Suchergebnisse - "Hasan, Syed Shahzad"

PubPharm (10)

1

The use of tenofovir in patients with COVID-19

enthalten in: HIV medicine | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentIn: HIV Med. 2022 Sep;23(8):929-930. - PMID 35194929

2

Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19 : a systematic review and meta-analysis of randomized trials

enthalten in: Expert review of anti-infective therapy | 2022

von Kow, C. | Javed, A. | Ramachandram, D. | +1

3

The use of remdesivir for the management of patients with moderate-to-severe COVID-19 : a systematic review

enthalten in: Expert review of anti-infective therapy | 2022

von Thiruchelvam, K. | Kow, C. | Hadi, M. | +1

4

The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19 : a systematic review and meta-analysis of randomized trials

enthalten in: Immunopharmacology and immunotoxicology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

5

Future of antivirals in COVID-19 : The case of favipiravir

enthalten in: International immunopharmacology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

6

The effect of tocilizumab on mortality in hospitalized patients with COVID-19 : a meta-analysis of randomized controlled trials

enthalten in: European journal of clinical pharmacology | 2021

von Kow, C. | Hasan, S.

7

SARS-CoV-2 infection pattern, transmission and treatment : Multi-center study in low to middle-income districts hospitals in Punjab, Pakistan

enthalten in: Pakistan journal of pharmaceutical sciences | 2021

von Kamran, S. | Mustafa, Z. | Rao, A. | +7

8

Effect of remdesivir on mortality in patients with COVID-19 : A meta-analysis of randomized control trials

enthalten in: Journal of medical virology | 2021

von Kow, C. | Aldeyab, M. | Hasan, S.

9

Interferon-based therapies in COVID-19

enthalten in: International immunopharmacology | 2021

von Kow, C. | Hasan, S.

10

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19

enthalten in: European journal of clinical pharmacology | 2021

von Kow, C. | Aldeyab, M. | Hasan, S.

1
[1]